Soho Square, Mumbai has bagged yet another big account this year. Following the two big wins of Vasmol and Faber in January and February, they have now been roped in to handle the brand duties for Nicotex – Cipla Health’s smoking cessation gum.
Speaking on the association, Himava Nath, Head Marketing, Cipla Health said, “ Nicotex, the No. 1 doctor recommended brand in India, is the leading brand in smoking cessation. We have got significant growth for the brand, but we have only scratched the surface. Research shows that India is home to 12% of the world’s smokers, we feel SOHO can help us unlock the true potential of the brand and achieve our vision of a smoking free India.”
Commenting on the win, Samrat Bedi, Head of Office, Soho Square, Mumbai added, “ Cipla Health is a big brand and we are glad that they have given us this opportunity. Nicotex is the market leader in the category, and Soho has been entrusted with strengthening this position. Cipla Health chose us having noticed the value we bring to the existing brands we handle. Of course, this is a very big win.”
Cipla Health (a newly formed subsidiary of Cipla) with a vision to improve the lives of Indian consumers, plans to position itself as a trusted consumer healthcare brand by providing innovative, consumer friendly products.
Shashank Lanjekar, Senior VP – Strategic Planning, Soho Square, Mumbai said, “Nicotex is a challenging brand on two counts. Firstly, it operates in that rare category where prospects will stop buying the product forever after about 12-15 weeks if they use it correctly. Secondly, it’s an assignment of classic behaviour change albeit with a difference. Here, it’s addiction we are addressing. And that’s as difficult as it gets. So yes, we are very excited to get started.”
Soho Square currently works with a number of brands including Tata Motors, YES Bank, H&R Johnson and Bisleri. The agency has recently been in the news for the launch of Bisleri's soft-drinks range and Franklin Templeton’s “Good EMI” campaign promoting SIPs.